John Gunn - Dodge & Cox
Holding/activity history for Elevance Health Inc. (ELV)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,300 | <0.01 | $292.75 | $380,575 | SEC | ||
| 2025 Q4 | 1,300 | <0.01 | $350.55 | $455,715 | SEC | ||
| 2025 Q3 | 1,300 | <0.01 | $323.12 | $420,056 | SEC | ||
| 2025 Q2 | 1,300 | <0.01 | Add 8.33% | $388.96 | $505,648 | SEC | |
| 2025 Q1 | 1,200 | <0.01 | Add 9.09% | $434.96 | $521,952 | SEC | |
| 2024 Q4 | 1,100 | <0.01 | $368.90 | $405,790 | SEC | ||
| 2024 Q3 | 1,100 | <0.01 | $520.00 | $572,000 | SEC | ||
| 2024 Q2 | 1,100 | <0.01 | $541.86 | $596,046 | SEC | ||
| 2024 Q1 | 1,100 | <0.01 | $518.54 | $570,394 | SEC | ||
| 2023 Q4 | 1,100 | <0.01 | $471.56 | $518,716 | SEC | ||
| 2023 Q3 | 1,100 | <0.01 | $435.42 | $478,962 | SEC | ||
| 2023 Q2 | 1,100 | <0.01 | $444.29 | $488,719 | SEC | ||
| 2023 Q1 | 1,100 | <0.01 | $459.81 | $505,791 | SEC | ||
| 2022 Q4 | 1,100 | <0.01 | $512.97 | $564,267 | SEC | ||
| 2022 Q3 | 1,100 | <0.01 | $454.55 | $500,000 | SEC | ||
| 2022 Q2 | 1,100 | <0.01 | $482.73 | $531,000 | SEC | ||
| 2022 Q1 | 1,100 | <0.01 | $490.91 | $540,000 | SEC | ||
| 2021 Q4 | 1,100 | <0.01 | $463.64 | $510,000 | SEC | ||
| 2021 Q3 | 1,100 | <0.01 | $372.73 | $410,000 | SEC | ||
| 2021 Q2 | 1,100 | <0.01 | $381.82 | $420,000 | SEC | ||
| 2021 Q1 | 1,100 | <0.01 | $359.09 | $395,000 | SEC | ||
| 2020 Q4 | 1,100 | <0.01 | $320.91 | $353,000 | SEC | ||
| 2020 Q3 | 1,100 | <0.01 | Reduce 12.70% | $268.18 | $295,000 | SEC | |
| 2020 Q2 | 1,260 | <0.01 | Add 5.00% | $262.70 | $331,000 | SEC | |
| 2020 Q1 | 1,200 | <0.01 | $226.67 | $272,000 | SEC | ||
| 2019 Q4 | 1,200 | <0.01 | $301.67 | $362,000 | SEC | ||
| 2019 Q3 | 1,200 | <0.01 | $240.00 | $288,000 | SEC | ||
| 2019 Q2 | 1,200 | <0.01 | $282.50 | $339,000 | SEC | ||
| 2019 Q1 | 1,200 | <0.01 | Reduce 14.29% | $286.67 | $344,000 | SEC | |
| 2018 Q4 | 1,400 | <0.01 | $262.86 | $368,000 | SEC | ||
| 2018 Q3 | 1,400 | <0.01 | $274.29 | $384,000 | SEC | ||
| 2018 Q2 | 1,400 | <0.01 | $237.86 | $333,000 | SEC | ||
| 2018 Q1 | 1,400 | <0.01 | Reduce 36.36% | <0.01 | $220.00 | $308,000 | SEC |
| 2017 Q4 | 2,200 | <0.01 | $225.00 | $495,000 | SEC | ||
| 2017 Q3 | 2,200 | <0.01 | Reduce 96.68% | <0.01 | $190.00 | $418,000 | SEC |
| 2017 Q2 | 66,350 | 0.01 | Reduce 97.66% | 0.40 | $188.12 | $12,482,000 | SEC |
| 2017 Q1 | 2,839,368 | 0.41 | Reduce 5.51% | 0.02 | $165.38 | $469,575,000 | SEC |
| 2016 Q4 | 3,005,018 | 0.39 | Reduce 3.42% | 0.01 | $143.77 | $432,031,000 | SEC |
| 2016 Q3 | 3,111,405 | 0.37 | Reduce 2.93% | 0.01 | $125.31 | $389,890,000 | SEC |
| 2016 Q2 | 3,205,245 | 0.43 | Reduce 5.24% | 0.03 | $131.34 | $420,977,000 | SEC |
| 2016 Q1 | 3,382,350 | 0.48 | Add 13.75% | 0.06 | $138.99 | $470,113,000 | SEC |
| 2015 Q4 | 2,973,449 | 0.42 | Add 118,837.96% | 0.42 | $139.44 | $414,618,000 | SEC |
| 2015 Q3 | 2,500 | <0.01 | Reduce 16.67% | <0.01 | $140.00 | $350,000 | SEC |
| 2015 Q2 | 3,000 | <0.01 | $164.00 | $492,000 | SEC | ||
| 2015 Q1 | 3,000 | <0.01 | $154.33 | $463,000 | SEC | ||
| 2014 Q4 | 3,000 | <0.01 | Buy | <0.01 | $125.67 | $377,000 | SEC |